RESUMEN
Injection of adjuvant (Mycobacterium butyricum suspended in mineral oil) into rats produces an immune reaction that characteristically involves inflammatory destruction of cartilage and bone of the distal joints with concomitant swelling of surrounding tissues. Adjuvant-induced arthritis in rats is commonly used to evaluate compounds that might be of potential use as drugs for treatment of rheumatoid arthritis and other chronic inflammatory conditions. This unit describes a method for inducing arthritis by injecting adjuvant into the tail and evaluating a test compound for the ability to inhibit the inflammatory response.
Asunto(s)
Artritis Experimental/patología , Modelos Animales de Enfermedad , Adyuvantes Inmunológicos/toxicidad , Animales , Artritis Experimental/inducido químicamente , Artritis Experimental/inmunología , Femenino , Distribución Aleatoria , Ratas , Ratas Endogámicas LewAsunto(s)
Antiinflamatorios no Esteroideos/efectos adversos , Modelos Animales de Enfermedad , Inflamación/tratamiento farmacológico , Úlcera Péptica/inducido químicamente , Animales , Antiinflamatorios no Esteroideos/uso terapéutico , Femenino , Indometacina/efectos adversos , Indometacina/uso terapéutico , Intestino Delgado/efectos de los fármacos , Intestino Delgado/patología , Úlcera Péptica/patología , Ratas , Estómago/efectos de los fármacos , Estómago/patologíaRESUMEN
IkappaB kinase-alpha and -beta (IKK-alpha and IKK-beta), the catalytic subunits of the IKK complex, phosphorylate IkappaB proteins on specific serine residues, thus targeting IkappaB for degradation and activating the transcription factor NF-kappaB. To elucidate the in vivo function of IKK-beta, we generated IKK-beta-deficient mice. The homozygous mouse embryo dies at approximately 14.5 days of gestation due to liver degeneration and apoptosis. IKK-beta-deficient embryonic fibroblasts have both reduced basal NF-kappaB activity and impaired cytokine-induced NF-kappaB activation. Similarly, basal and cytokine-inducible kinase activities of the IKK complex are greatly reduced in IKK-beta-deficient cells. These results indicate that IKK-beta is crucial for liver development and regulation of NF-kappaB activity and that IKK-alpha can only partially compensate for the loss of IKK-beta.
Asunto(s)
Muerte Fetal/inmunología , Hígado/embriología , Hígado/patología , Proteínas Quinasas Activadas por Mitógenos , FN-kappa B/metabolismo , Proteínas Serina-Treonina Quinasas/deficiencia , Proteínas Serina-Treonina Quinasas/genética , Animales , Proteínas Quinasas Dependientes de Calcio-Calmodulina/genética , Proteínas Quinasas Dependientes de Calcio-Calmodulina/metabolismo , Línea Celular , Cruzamientos Genéticos , Activación Enzimática/genética , Activación Enzimática/inmunología , Femenino , Muerte Fetal/enzimología , Muerte Fetal/genética , Humanos , Quinasa I-kappa B , Interleucina-6/biosíntesis , Proteínas Quinasas JNK Activadas por Mitógenos , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Transfección/inmunología , Factor de Necrosis Tumoral alfa/biosíntesis , Factor de Necrosis Tumoral alfa/farmacología , Factor de Necrosis Tumoral alfa/fisiologíaAsunto(s)
Proteínas Adaptadoras Transductoras de Señales , Interleucina-1/metabolismo , FN-kappa B/metabolismo , Receptores Inmunológicos , Factor de Necrosis Tumoral alfa/metabolismo , Animales , Antígenos CD/metabolismo , Antígenos de Diferenciación/metabolismo , Proteínas Portadoras/metabolismo , Proteína de Dominio de Muerte Asociada a Fas , Humanos , Quinasa I-kappa B , Quinasas Asociadas a Receptores de Interleucina-1 , Ratones , Ratones Noqueados , Factor 88 de Diferenciación Mieloide , Proteínas Quinasas/metabolismo , Proteínas Serina-Treonina Quinasas/genética , Proteínas Serina-Treonina Quinasas/metabolismo , Proteínas/metabolismo , Proteína Serina-Treonina Quinasas de Interacción con Receptores , Receptores de Interleucina-1/metabolismo , Receptores del Factor de Necrosis Tumoral/metabolismo , Receptores Tipo I de Factores de Necrosis Tumoral , Transducción de Señal , Factor 1 Asociado a Receptor de TNF , Factor 2 Asociado a Receptor de TNF , Factor 6 Asociado a Receptor de TNFRESUMEN
In vitro, IL-6 is the main inducer of the human C-reactive protein (CRP) gene, and IL-1 and steroids can enhance this effect. However, in mice, IL-6 is necessary but not sufficient for induction of the human CRP transgene, and testosterone is required for its constitutive expression by males. To examine the relative contributions of testosterone and IL-6 in the regulation of CRP gene expression, we produced CRP-transgenic (CRPtg), IL-6-deficient (IL-6-/-) mice. Male CRPtg/IL-6-/- mice expressed CRP constitutively, but CRP levels were not increased after injection of LPS. However, acute-phase CRP levels were attained after injection of IL-6. In contrast, female CRPtg/IL-6-/- mice did not express CRP constitutively or after administration of LPS, IL-6, IL-1, or IL-6 plus IL-1. Like males, testosterone-treated CRPtg/IL-6-/- females expressed CRP constitutively, and their transgene responded to injection of IL-6. The endogenous acute-phase protein serum amyloid P (SAP) was expressed constitutively equally by male and female IL-6-/- mice, responded minimally to LPS, and did not respond to either IL-6 or IL-1 alone. Acute-phase levels of SAP were induced in IL-6-/- mice by injection of IL-6 together with IL-1 or LPS. We conclude that in vivo, both constitutive and IL-6-dependent acute-phase expression of the CRP transgene require testosterone. In contrast, testosterone is not required for expression of the SAP gene, which requires IL-1 plus IL-6 for acute-phase induction.
Asunto(s)
Proteína C-Reactiva/genética , Regulación de la Expresión Génica/inmunología , Interleucina-6/fisiología , Testosterona/fisiología , Factores de Edad , Animales , Proteína C-Reactiva/biosíntesis , Proteína C-Reactiva/metabolismo , Combinación de Medicamentos , Femenino , Humanos , Inyecciones Intraperitoneales , Interleucina-1/administración & dosificación , Interleucina-6/administración & dosificación , Lipopolisacáridos/administración & dosificación , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Ratones Transgénicos , Componente Amiloide P Sérico/biosíntesis , Factores Sexuales , Testosterona/administración & dosificación , Transgenes/inmunologíaRESUMEN
The Listeria monocytogenes (L. monocytogenes) infection model has been a useful system to evaluate the cellular interactions leading to host immunity. The initiation of the innate immune response in naive animals and subsequent progression to acquired immunity represent an integrated system with numerous layers of complexity. Coincident with experimental infection is the induction of cytokines. Cytokines, which are soluble mediators of cell growth, maintenance and function, from a network of pleiotropic stimuli that serve as one of the main driving forces for the progressive development of cellular responses. A variety of in vivo approaches, such as injection of the recombinant cytokines themselves or antibodies to neutralize their activity, have been used to define these stimuli. Perhaps one of the most useful tools is that of germline-manipulated animals. One of the many cytokines implicated in resistance to L. monocytogenes infection is interleukin (IL)-6, a molecule associated with diverse infectious and pathophysiological disease states. This review concentrates on various cytokines (IL-1, TNF alpha, IFN-gamma, IL-12, IL-10 and the colony-stimulating factors (CSF)) thought to play a role during the innate host response to L. monocytogenes infection, with a special emphasis on studies using IL-6-deficient mice. Additionally, we show unpublished data obtained when the concepts learned from L. monocytogenes infection in IL-6-deficient mice were applied to other infection models.
Asunto(s)
Citocinas/inmunología , Interleucina-6/inmunología , Listeriosis/inmunología , Animales , Inmunidad Activa , Inmunidad Innata , Interleucina-6/deficiencia , Listeriosis/mortalidad , Macrófagos/inmunología , Ratones , Neutrófilos/inmunologíaRESUMEN
The role of interleukin-6 (IL-6) in the pathogenesis of toxoplasmic encephalitis (TE) was examined by using IL-6-targeted mutant (IL-6(-/-)) mice. At 4 and 8 weeks after infection with the ME49 strain of Toxoplasma gondii, significantly greater numbers of T. gondii cysts and areas of inflammation associated with tachyzoites were observed in brains of IL-6(-/-) mice than in those of control mice. Large areas of necrosis were observed only in brains of IL-6(-/-) mice. Tachyzoites were frequently detected in the areas of necrosis, suggesting that necrosis was caused by proliferation of the parasite. These results indicate that IL-6 is protective against development of TE by preventing formation of T. gondii cysts and proliferation of tachyzoites in brains of infected mice. Whereas in brains of control mice, large numbers of inflammatory cells were always observed in areas where tachyzoites were detected, in brains of IL-6(-/-) mice, only small numbers of inflammatory cells were observed in many areas with tachyzoites. Lymphocyte preparations isolated from brains of infected control mice had significantly higher ratios of gamma/delta T cells and CD4+ alpha/beta T cells but lower ratios of CD8+ alpha/beta T cells compared to those of infected IL-6(-/-) mice. There were no differences in the ratios of these T-cell subsets in spleens between these mice. The amounts of mRNA for gamma interferon (IFN-gamma) detected by reverse transcriptase PCR were significantly smaller in brains of IL-6(-/-) mice than in those of control mice, whereas amounts of IL-10 mRNA were greater in the former than in the latter. IL-6 mRNA was detected only in infected control mice. The protective activity of IL-6 against development of TE appears to be through its ability to stimulate IFN-gamma production and induce infiltration and accumulation of different T-cell subsets in brains of infected mice.
Asunto(s)
Encefalitis/inmunología , Interleucina-6/deficiencia , Toxoplasmosis Animal/inmunología , Animales , Citocinas/genética , Femenino , Interleucina-6/fisiología , Masculino , Ratones , Ratones Endogámicos C57BL , ARN Mensajero/análisis , Subgrupos de Linfocitos T/inmunologíaRESUMEN
Interleukin-6 (IL-6) is a multipotential cytokine detected in the serum of patients or experimental animals undergoing bacterial sepsis. To date, the role of IL-6 in gram-negative sepsis models has been controversial. We have used IL-6-deficient mice to investigate the role of IL-6 during virulent Escherichia coli infection and in lipopolysaccharide (LPS)-induced mortality. In this report we describe an increased susceptibility of IL-6-deficient mice to E. coli infection in terms of mortality and accumulation of viable bacteria in tissues, indicating a protective role for IL-6 during the immune response against E. coli. In contrast, mortality rates of IL-6-deficient mice and control animals undergoing LPS-induced shock did not differ, indicating that IL-6 was inconsequential for survival in this model. Furthermore, we have shown that neutrophils were crucial for resistance to E. coli in normal mice. IL-6-deficient mice were unable to efficiently induce neutrophilia in the bloodstream immediately following challenge with E. coli, in contrast to a characteristic neutrophilia induced in control animals. Prophylactic treatment of the mutant animals with recombinant IL-6 protein reverted both the deficit of neutrophilia and the accumulation of bacteria in tissues. These data clarify the role of IL-6 as protective in virulent E. coli infection and suggest that the protective effect may be at least partially mediated through neutrophils.
Asunto(s)
Infecciones por Escherichia coli/inmunología , Interleucina-6/inmunología , Choque Séptico/inmunología , Animales , Escherichia coli/crecimiento & desarrollo , Escherichia coli/patogenicidad , Infecciones por Escherichia coli/mortalidad , Inmunidad Innata , Interleucina-6/deficiencia , Interleucina-6/genética , Interleucina-6/farmacología , Hígado/microbiología , Ratones , Ratones Mutantes , Neutrófilos/inmunología , Proteínas Recombinantes/farmacología , Choque Séptico/mortalidad , Bazo/microbiología , Análisis de Supervivencia , VirulenciaRESUMEN
We have produced interleukin-6 (IL-6)-deficient mice to examine, in vivo, the wide variety of biological activities attributed to this multifunctional cytokine. To investigate the role of IL-6 during infectious disease, IL-6-deficient mice were challenged with sublethal doses of Listeria monocytogenes, a facultative intracellular bacterium. While normal control animals were able to clear the infection, mutant animals exhibited a high mortality rate and showed uncontrolled replication of the bacteria in the spleen and liver at 2 and 3 days postinfection. Sections of infected tissues showed an increase in the number and severity of inflammatory foci. All aspects of this phenotype in the mutant animals were completely reverted upon administration of recombinant murine IL-6 (rIL-6). Various parameters of natural killer (NK) cell and macrophage function were unaffected in the challenge of the mutant animals. However, IL-6-deficient animals failed to mount peripheral blood neutrophilia in response to listeriosis, whereas control animals displayed a prominent neutrophilia in the blood at 24 and 48 h postinfection. Additionally, we analyzed the efficacy of rIL-6 in protecting animals devoid of lymphocytes or devoid of neutrophils during listeriosis. Administration of rIL-6 was protective to animals devoid of lymphocytes, suggesting that the rIL-6 protective effect was not mediated through lymphocytes. In contrast, control and mutant animals depleted of neutrophils were refractory to the rIL-6 protective effect. These data suggest that IL-6 is critical early during listeriosis, perhaps acting by stimulating neutrophils either directly or indirectly. Additionally, these data show a promising therapeutic potential for rIL-6 administration during opportunistic infection.
Asunto(s)
Interleucina-6/deficiencia , Listeriosis/inmunología , Neutrófilos/inmunología , Animales , Femenino , Interferón gamma/biosíntesis , Interleucina-6/farmacología , Células Asesinas Naturales/inmunología , Listeria monocytogenes/crecimiento & desarrollo , Linfocitos/inmunología , Activación de Macrófagos , Masculino , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C57BL , Ratones Endogámicos DBA , Proteínas Recombinantes/farmacologíaRESUMEN
Interleukin-6 is an essential mediator of the bone loss caused by loss of estrogens. Because loss of androgens also causes bone loss, we have examined whether the IL-6 gene is regulated by androgens, and whether IL-6 plays a role in the bone loss caused by androgen deficiency. Both testosterone and dihydrotestosterone inhibited IL-6 production by murine bone marrow-derived stromal cells. In addition, testosterone, dihydrotestosterone, and adrenal androgens inhibited the expression of a chloramphenicol acetyl transferase reporter plasmid driven by the human IL-6 promoter in HeLa cells cotransfected with an androgen receptor expression plasmid; however, these steroids were ineffective when the cells were cotransfected with an estrogen receptor expression plasmid. In accordance with the in vitro findings, orchidectomy in mice caused an increase in the replication of osteoclast progenitors in the bone marrow which could be prevented by androgen replacement or administration of an IL-6 neutralizing antibody. Moreover, bone histomorphometric analysis of trabecular bone revealed that, in contrast to IL-6 sufficient mice which exhibited increased osteoclast numbers and bone loss following orchidectomy, IL-6 deficient mice (generated by targeted gene disruption) did not. This evidence demonstrates that male sex steroids, acting through the androgen-specific receptor, inhibit the expression of the IL-6 gene; and that IL-6 mediates the upregulation of osteoclastogenesis and therefore the bone loss caused by androgen deficiency, as it does in estrogen deficiency.
Asunto(s)
Huesos/fisiología , Dihidrotestosterona/farmacología , Interleucina-6/metabolismo , Osteoclastos/fisiología , Receptores Androgénicos/fisiología , Testosterona/farmacología , Animales , Resorción Ósea/fisiopatología , Células Cultivadas , Expresión Génica/efectos de los fármacos , Células HeLa , Homeostasis/efectos de los fármacos , Humanos , Técnicas In Vitro , Interleucina-6/genética , Masculino , Ratones , Ratones Noqueados , Orquiectomía , ARN Mensajero/genética , Receptores de Estrógenos/fisiología , Transcripción Genética/efectos de los fármacosRESUMEN
Renal adenocarcinomas and/or extremely enlarged thymuses (up to 250 times normal size) were observed in 60 of 78 mice in a transgenic line containing a single copy of the BK virus (BKV) early region. Enlarged thymuses from different mice displayed thymoproliferative disorders of varying severity, ranging from extreme hyperplasia to thymomas and lymphomas. All kidney tumor DNAs analyzed contained highly amplified BKV sequences with multiple rearrangements in cellular DNA flanking the transgene, whereas amplification and rearrangement were observed only in some enlarged thymus DNAs. Expression of BKV T antigens was restricted to epithelial cells of kidney tumors and enlarged thymuses and was not detected in any normal tissues. Although thymocytes proliferated to numbers much greater than normal in the enlarged thymuses, no T antigen expression was detected in thymocytes.